239 related articles for article (PubMed ID: 33381151)
1. Integrated Analysis of lncRNA-Mediated ceRNA Network Reveals a Prognostic Signature for Hepatocellular Carcinoma.
Sun JR; Kong CF; Xiao KM; Yang JL; Qu XK; Sun JH
Front Genet; 2020; 11():602542. PubMed ID: 33381151
[TBL] [Abstract][Full Text] [Related]
2. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
3. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma.
Chen R; Chen Y; Huang W; Zhao Y; Luo W; Lin J; Wang Z; Yang J
Aging (Albany NY); 2021 Jul; 13(13):17607-17628. PubMed ID: 34237706
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks.
Zhao X; Bai Z; Li C; Sheng C; Li H
Biomed Res Int; 2020; 2020():8765461. PubMed ID: 32382578
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of a competing endogenous RNA network reveals a ferroptosis-related 6-lncRNA prognostic signature in clear cell renal cell carcinoma.
Zheng Q; Gong Z; Lin S; Ou D; Lin W; Shen P
Adv Clin Exp Med; 2024 Mar; ():. PubMed ID: 38470002
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
Cao J; Wu L; Lei X; Shi K; Shi L; Shi Y
Bioengineered; 2021 Dec; 12(1):673-681. PubMed ID: 33622186
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma.
Deng X; Bi Q; Chen S; Chen X; Li S; Zhong Z; Guo W; Li X; Deng Y; Yang Y
Front Mol Biosci; 2020; 7():611626. PubMed ID: 33505990
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Prognostic Signature Composed of GPI, IL22RA1, CCT6A and SPOCK1 for Lung Adenocarcinoma Based on Bioinformatic Analysis of lncRNA-Mediated ceRNA Network and Sample Validation.
Tang W; Lu Q; Zhu J; Zheng X; Fang N; Ji S; Lu F
Front Oncol; 2022; 12():844691. PubMed ID: 35433415
[TBL] [Abstract][Full Text] [Related]
12. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L
Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X
J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
Liu N; Liu Z; Liu X; Chen H
Front Oncol; 2019; 9():935. PubMed ID: 31649871
[TBL] [Abstract][Full Text] [Related]
15. The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma.
Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; de Castria TB; Zeng B; Zong Z; Zhou T
Ann Transl Med; 2022 Jul; 10(14):766. PubMed ID: 35965795
[TBL] [Abstract][Full Text] [Related]
16. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G
Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420
[TBL] [Abstract][Full Text] [Related]
17. Construction of a ceRNA Network and a Prognostic lncRNA Signature associated with Vascular Invasion in Hepatocellular Carcinoma based on Weighted Gene Co-Expression Network Analysis.
Tao H; Li J; Liu J; Yuan T; Zhang E; Liang H; Huang Z
J Cancer; 2021; 12(13):3754-3768. PubMed ID: 34093785
[No Abstract] [Full Text] [Related]
18. Integrated Bioinformatic Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Endometrial Cancer.
Xia L; Wang Y; Meng Q; Su X; Shen J; Wang J; He H; Wen B; Zhang C; Xu M
Front Oncol; 2019; 9():448. PubMed ID: 31192139
[TBL] [Abstract][Full Text] [Related]
19. Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic lncRNA Signature in Bladder Cancer.
Peng M; Cheng X; Xiong W; Yi L; Wang Y
Front Oncol; 2021; 11():684242. PubMed ID: 34408977
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinoma.
Liao X; Wang X; Huang K; Han C; Deng J; Yu T; Yang C; Huang R; Liu X; Yu L; Zhu G; Su H; Qin W; Zeng X; Han B; Han Q; Liu Z; Zhou X; Gong Y; Liu Z; Huang J; Winkler CA; O'Brien SJ; Ye X; Peng T
J Cancer; 2019; 10(14):3267-3283. PubMed ID: 31289599
[No Abstract] [Full Text] [Related]
[Next] [New Search]